Stoke Therapeutics

Developer of antisense oligonucleotide drugs for treating inherited diseases by targeting RNA splicing

placeBedford, Massachusetts, United States calendar_todayFounded 2014 groups117 employees language stoketherapeutics.com

Registered entities

Social engagement

Social engagement: 21.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Apple Tree Partners, RTW Investments.

Investor typeCountShare
Venture capital457%
Other / undisclosed343%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

10 Jun 2026 · Director, Strategic Purchasing · Waltham

14 Aug 2025 · Senior Director, Market Access Strategy & Marketing New Bedford, Massachusetts, · Brockton

30 May 2025 · Manager, Information Security · New Bedford

30 May 2025 · Clinical Trial Manager, Clinical Operations · New Bedford

Based on job postings tracked across public sources.

Recent activity

30 Jun 2026
Milestone
regulatory
29 Jun 2026
Recognition
25 Jun 2026
Event
2026 DSF Family & Professional Conference
Coming soon